Clinical trial
Pregnenolone for the Treatment of Alcohol Use Disorder
NCT05781009 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pregnenolone for the Treatment of Alcohol Use Disorder
- Lead sponsor
- Yale University
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- January 8, 2024
- Completion date
- July 31, 2028
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol use disorder